Aldeyra Therapeutics (ALDX) PT Raised to $11 at Oppenheimer Following Positive TRANQUILITY-2 Data
Tweet Send to a Friend
Oppenheimer analyst Justin Kim raised the price target on Aldeyra Therapeutics (NASDAQ: ALDX) to $11.00 (from $10.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
